港通控股(00032.HK)拟认购合伙企业的有限合伙权益
格隆汇 12 月 18日丨港通控股(00032.HK)发布公告,2020年12月17日,公司间接全资公司Phenomenal Combo Limited作为认购方与合伙企业Banner Ridge DSCO Fund I (Offshore), LP签订认购协议,据此,认购方同意以资本承担(认购方根据认购协议同意对合伙企业作出的资本承担,金额为5000万美元)认购合伙企业的有限合伙权益。
合伙企业Banner Ridge DSCO Fund I (Offshore), LP目标及目的包括透过其于境内基金拥有的合伙权益(其中包括)投资于主要由独立投资组合管理人所管理的投资基金发行的证券。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.